2015 JITC Best Paper Award Recipients

The Journal for ImmunoTherapy of Cancer (JITC) Best Paper Awards celebrate excellence in scientific research and are awarded to researchers demonstrating leadership in the field as well as innovation and high-quality execution and discussion in their manuscripts. Papers published in the last 12 months authored by Society for Immunotherapy of Cancer (SITC) members were eligible for nomination for this award.

JITC Best Basic Science Paper

Articles nominated in this category present innovative research in basic medical sciences that have a direct relevance to future research in clinical medicine.

WeiqingJing2.jpgWeiqing Jing, MD
Medical College of Wisconsin

Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
Weiqing Jing, Jill A. Gershan, James Weber, Dominique Tlomak, Laura McOlash, Catherine Sabatos-Peyton, Bryon D. Johnson

Journal for Immunotherapy of Cancer 2015, 3:2

JITC Best Clinical/Translational Paper

Papers in this category present clinical research that has a clear potential to optimize patient care, with particular emphasis on high quality randomized controlled trials, novel combination treatments, therapies, novel diagnostic or prognostic insights and new insights into mechanism of action.

SaskiaSantegoets.jpgSaskia Santegoets, PhD
VU University Medical Center Cancer Center Amsterdam

“Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab”
Saskia Santegoets, Anita Stam, Sinéad M. Lougheed, Helen Gall, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Rik J. Scheper, Winald R. Gerritsen, Alfons van den Eertwegh, Tanja D. de Gruijl

Journal for Immunotherapy of Cancer 2014, 2:31